677C to T mutation in the 5,10-methylenetetrahydrofolate reductase (MTHFR) gene and plasma homocyst(e)ine levels in patients with TIA or minor stroke

It was the aim of this study to determine the associations of clinical and laboratory data with plasma homocyst(e)ine levels in patients with transient ischemic attack (TIA) or minor stroke (MS), with special reference to their 677C to T mutation status in the 5,10-methylenetetrahydrofolate reductas...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the neurological sciences 1998-03, Vol.155 (2), p.156-162
Hauptverfasser: Lalouschek, Wolfgang, Aull, Susanne, Korninger, Lisa, Mannhalter, Christine, Pabinger-Fasching, Ingrid, Schmid, Rainer W, Peter Schnider, Zeiler, Karl
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 162
container_issue 2
container_start_page 156
container_title Journal of the neurological sciences
container_volume 155
creator Lalouschek, Wolfgang
Aull, Susanne
Korninger, Lisa
Mannhalter, Christine
Pabinger-Fasching, Ingrid
Schmid, Rainer W
Peter Schnider
Zeiler, Karl
description It was the aim of this study to determine the associations of clinical and laboratory data with plasma homocyst(e)ine levels in patients with transient ischemic attack (TIA) or minor stroke (MS), with special reference to their 677C to T mutation status in the 5,10-methylenetetrahydrofolate reductase (5,10-MTHFR) gene. Seventy-six patients with TIA or MS were investigated at least 3 months after their (last) clinical event. By means of univariate analysis, significant correlations of homocyst(e)ine levels with male gender ( P
doi_str_mv 10.1016/S0022-510X(97)00311-0
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_79813192</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0022510X97003110</els_id><sourcerecordid>79813192</sourcerecordid><originalsourceid>FETCH-LOGICAL-c389t-509eb266cae905a7f87eb2a25d74f06e1de965fe684c6675a0538e5a070b117b3</originalsourceid><addsrcrecordid>eNqFkV2LEzEUhgdR1rr6ExZyIdKCoyeZzdeVLMV1F1YEreBdSDNnbHRm0k0yK_0h_l_TbemtNzmE9zkfvG9VXVB4R4GK998AGKs5hR9zLRcADaU1PKlmVElVc6Wap9XshDyvXqT0CwCEUvqsOtNcMCZgVv0VUi5JDmRFhinb7MNI_EjyBgl_S6EeMG92PY6YMUe72bUxdKG3GUnEdnLZJiTzz6ub668L8rNgxI4t2fY2DZZswhDcLuU5LnxRenzAPu2nb8seHHMif3zekNXtFQmRDH4sb8ox_MaX1bPO9glfHet59f3642p5U999-XS7vLqrXaN0rjloXDMhnEUN3MpOyfK3jLfysgOBtEUteIdCXTohJLfAG4WlSFhTKtfNefXmMHcbw_2EKZvBJ4d9b0cMUzJSK9pQzQrID6CLIaWIndlGP9i4MxTMPg7zGIfZe220NI9xGCh9F8cF03rA9tR19L_or4-6Tc72XbSj8-mEMaopY03BPhywYiA-eIwmueKgw9ZHdNm0wf_nkH9aF6bl</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>79813192</pqid></control><display><type>article</type><title>677C to T mutation in the 5,10-methylenetetrahydrofolate reductase (MTHFR) gene and plasma homocyst(e)ine levels in patients with TIA or minor stroke</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Lalouschek, Wolfgang ; Aull, Susanne ; Korninger, Lisa ; Mannhalter, Christine ; Pabinger-Fasching, Ingrid ; Schmid, Rainer W ; Peter Schnider ; Zeiler, Karl</creator><creatorcontrib>Lalouschek, Wolfgang ; Aull, Susanne ; Korninger, Lisa ; Mannhalter, Christine ; Pabinger-Fasching, Ingrid ; Schmid, Rainer W ; Peter Schnider ; Zeiler, Karl</creatorcontrib><description><![CDATA[It was the aim of this study to determine the associations of clinical and laboratory data with plasma homocyst(e)ine levels in patients with transient ischemic attack (TIA) or minor stroke (MS), with special reference to their 677C to T mutation status in the 5,10-methylenetetrahydrofolate reductase (5,10-MTHFR) gene. Seventy-six patients with TIA or MS were investigated at least 3 months after their (last) clinical event. By means of univariate analysis, significant correlations of homocyst(e)ine levels with male gender ( P<0.02), age ( P<0.0005), creatinine levels ( P<0.0002), folate levels (inversely, P<0.05), and alcohol use ( P<0.02) were found, but not with vitamin B 12 levels. Multivariate regression analysis, including age, creatinine levels, and folate levels as independent variables, revealed age ( P<0.01) and creatinine levels ( P<0.02) to be significantly correlated with homocyst(e)ine levels. After adjustment for age, creatinine levels and homocyst(e)ine levels remained significantly correlated to each other ( P<0.005), whereas the relation between folate levels and homocyst(e)ine levels was no longer significant ( P=0.10). Mutation-positive patients exhibited moderately and statistically non-significantly higher homocyst(e)ine levels than mutation-negative patients, particularly those who were homozygous positive. Homocyst(e)ine levels were closely correlated with creatinine levels ( P<0.0002) and with folate levels (inversely, P<0.05), but only in mutation-positive and not in mutation-negative patients. Homozygous positive, heterozygous positive, and mutation-negative patients did not differ with respect to clinical and laboratory data concerning ‘risk factors for stroke’ or co-existing vascular disease. In conclusion, the associations of creatinine levels and, inversely, of folate levels with plasma homocyst(e)ine levels in patients with TIA or MS are dependent on the 5,10-MTHFR mutation status. Significant correlations between these variables were found only in mutation-positive but not in mutation-negative patients.]]></description><identifier>ISSN: 0022-510X</identifier><identifier>EISSN: 1878-5883</identifier><identifier>DOI: 10.1016/S0022-510X(97)00311-0</identifier><identifier>PMID: 9562260</identifier><identifier>CODEN: JNSCAG</identifier><language>eng</language><publisher>Shannon: Elsevier B.V</publisher><subject>5,10-Methylenetetrahydrofolate Reductase (FADH2) ; Adult ; Aged ; Aged, 80 and over ; Analysis of Variance ; Biological and medical sciences ; Cerebrovascular diseases ; Cerebrovascular Disorders - blood ; Cerebrovascular Disorders - enzymology ; Cerebrovascular Disorders - genetics ; Creatinine ; Female ; Folate ; Folic Acid - blood ; Genetic disorders ; Homocyst(e)ine ; Homocysteine - blood ; Humans ; Ischemic Attack, Transient - blood ; Ischemic Attack, Transient - enzymology ; Ischemic Attack, Transient - genetics ; Male ; Medical sciences ; Methylenetetrahydrofolate Reductase (NADPH2) ; Middle Aged ; MTHFR ; Mutation - physiology ; Neurology ; Oxidoreductases - genetics ; Risk Factors ; Vascular diseases and vascular malformations of the nervous system ; Vitamin B 12 - blood</subject><ispartof>Journal of the neurological sciences, 1998-03, Vol.155 (2), p.156-162</ispartof><rights>1998 Elsevier Science B.V.</rights><rights>1998 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c389t-509eb266cae905a7f87eb2a25d74f06e1de965fe684c6675a0538e5a070b117b3</citedby><cites>FETCH-LOGICAL-c389t-509eb266cae905a7f87eb2a25d74f06e1de965fe684c6675a0538e5a070b117b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/S0022-510X(97)00311-0$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=2191223$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9562260$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lalouschek, Wolfgang</creatorcontrib><creatorcontrib>Aull, Susanne</creatorcontrib><creatorcontrib>Korninger, Lisa</creatorcontrib><creatorcontrib>Mannhalter, Christine</creatorcontrib><creatorcontrib>Pabinger-Fasching, Ingrid</creatorcontrib><creatorcontrib>Schmid, Rainer W</creatorcontrib><creatorcontrib>Peter Schnider</creatorcontrib><creatorcontrib>Zeiler, Karl</creatorcontrib><title>677C to T mutation in the 5,10-methylenetetrahydrofolate reductase (MTHFR) gene and plasma homocyst(e)ine levels in patients with TIA or minor stroke</title><title>Journal of the neurological sciences</title><addtitle>J Neurol Sci</addtitle><description><![CDATA[It was the aim of this study to determine the associations of clinical and laboratory data with plasma homocyst(e)ine levels in patients with transient ischemic attack (TIA) or minor stroke (MS), with special reference to their 677C to T mutation status in the 5,10-methylenetetrahydrofolate reductase (5,10-MTHFR) gene. Seventy-six patients with TIA or MS were investigated at least 3 months after their (last) clinical event. By means of univariate analysis, significant correlations of homocyst(e)ine levels with male gender ( P<0.02), age ( P<0.0005), creatinine levels ( P<0.0002), folate levels (inversely, P<0.05), and alcohol use ( P<0.02) were found, but not with vitamin B 12 levels. Multivariate regression analysis, including age, creatinine levels, and folate levels as independent variables, revealed age ( P<0.01) and creatinine levels ( P<0.02) to be significantly correlated with homocyst(e)ine levels. After adjustment for age, creatinine levels and homocyst(e)ine levels remained significantly correlated to each other ( P<0.005), whereas the relation between folate levels and homocyst(e)ine levels was no longer significant ( P=0.10). Mutation-positive patients exhibited moderately and statistically non-significantly higher homocyst(e)ine levels than mutation-negative patients, particularly those who were homozygous positive. Homocyst(e)ine levels were closely correlated with creatinine levels ( P<0.0002) and with folate levels (inversely, P<0.05), but only in mutation-positive and not in mutation-negative patients. Homozygous positive, heterozygous positive, and mutation-negative patients did not differ with respect to clinical and laboratory data concerning ‘risk factors for stroke’ or co-existing vascular disease. In conclusion, the associations of creatinine levels and, inversely, of folate levels with plasma homocyst(e)ine levels in patients with TIA or MS are dependent on the 5,10-MTHFR mutation status. Significant correlations between these variables were found only in mutation-positive but not in mutation-negative patients.]]></description><subject>5,10-Methylenetetrahydrofolate Reductase (FADH2)</subject><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Analysis of Variance</subject><subject>Biological and medical sciences</subject><subject>Cerebrovascular diseases</subject><subject>Cerebrovascular Disorders - blood</subject><subject>Cerebrovascular Disorders - enzymology</subject><subject>Cerebrovascular Disorders - genetics</subject><subject>Creatinine</subject><subject>Female</subject><subject>Folate</subject><subject>Folic Acid - blood</subject><subject>Genetic disorders</subject><subject>Homocyst(e)ine</subject><subject>Homocysteine - blood</subject><subject>Humans</subject><subject>Ischemic Attack, Transient - blood</subject><subject>Ischemic Attack, Transient - enzymology</subject><subject>Ischemic Attack, Transient - genetics</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Methylenetetrahydrofolate Reductase (NADPH2)</subject><subject>Middle Aged</subject><subject>MTHFR</subject><subject>Mutation - physiology</subject><subject>Neurology</subject><subject>Oxidoreductases - genetics</subject><subject>Risk Factors</subject><subject>Vascular diseases and vascular malformations of the nervous system</subject><subject>Vitamin B 12 - blood</subject><issn>0022-510X</issn><issn>1878-5883</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkV2LEzEUhgdR1rr6ExZyIdKCoyeZzdeVLMV1F1YEreBdSDNnbHRm0k0yK_0h_l_TbemtNzmE9zkfvG9VXVB4R4GK998AGKs5hR9zLRcADaU1PKlmVElVc6Wap9XshDyvXqT0CwCEUvqsOtNcMCZgVv0VUi5JDmRFhinb7MNI_EjyBgl_S6EeMG92PY6YMUe72bUxdKG3GUnEdnLZJiTzz6ub668L8rNgxI4t2fY2DZZswhDcLuU5LnxRenzAPu2nb8seHHMif3zekNXtFQmRDH4sb8ox_MaX1bPO9glfHet59f3642p5U999-XS7vLqrXaN0rjloXDMhnEUN3MpOyfK3jLfysgOBtEUteIdCXTohJLfAG4WlSFhTKtfNefXmMHcbw_2EKZvBJ4d9b0cMUzJSK9pQzQrID6CLIaWIndlGP9i4MxTMPg7zGIfZe220NI9xGCh9F8cF03rA9tR19L_or4-6Tc72XbSj8-mEMaopY03BPhywYiA-eIwmueKgw9ZHdNm0wf_nkH9aF6bl</recordid><startdate>19980305</startdate><enddate>19980305</enddate><creator>Lalouschek, Wolfgang</creator><creator>Aull, Susanne</creator><creator>Korninger, Lisa</creator><creator>Mannhalter, Christine</creator><creator>Pabinger-Fasching, Ingrid</creator><creator>Schmid, Rainer W</creator><creator>Peter Schnider</creator><creator>Zeiler, Karl</creator><general>Elsevier B.V</general><general>Elsevier Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19980305</creationdate><title>677C to T mutation in the 5,10-methylenetetrahydrofolate reductase (MTHFR) gene and plasma homocyst(e)ine levels in patients with TIA or minor stroke</title><author>Lalouschek, Wolfgang ; Aull, Susanne ; Korninger, Lisa ; Mannhalter, Christine ; Pabinger-Fasching, Ingrid ; Schmid, Rainer W ; Peter Schnider ; Zeiler, Karl</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c389t-509eb266cae905a7f87eb2a25d74f06e1de965fe684c6675a0538e5a070b117b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><topic>5,10-Methylenetetrahydrofolate Reductase (FADH2)</topic><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Analysis of Variance</topic><topic>Biological and medical sciences</topic><topic>Cerebrovascular diseases</topic><topic>Cerebrovascular Disorders - blood</topic><topic>Cerebrovascular Disorders - enzymology</topic><topic>Cerebrovascular Disorders - genetics</topic><topic>Creatinine</topic><topic>Female</topic><topic>Folate</topic><topic>Folic Acid - blood</topic><topic>Genetic disorders</topic><topic>Homocyst(e)ine</topic><topic>Homocysteine - blood</topic><topic>Humans</topic><topic>Ischemic Attack, Transient - blood</topic><topic>Ischemic Attack, Transient - enzymology</topic><topic>Ischemic Attack, Transient - genetics</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Methylenetetrahydrofolate Reductase (NADPH2)</topic><topic>Middle Aged</topic><topic>MTHFR</topic><topic>Mutation - physiology</topic><topic>Neurology</topic><topic>Oxidoreductases - genetics</topic><topic>Risk Factors</topic><topic>Vascular diseases and vascular malformations of the nervous system</topic><topic>Vitamin B 12 - blood</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lalouschek, Wolfgang</creatorcontrib><creatorcontrib>Aull, Susanne</creatorcontrib><creatorcontrib>Korninger, Lisa</creatorcontrib><creatorcontrib>Mannhalter, Christine</creatorcontrib><creatorcontrib>Pabinger-Fasching, Ingrid</creatorcontrib><creatorcontrib>Schmid, Rainer W</creatorcontrib><creatorcontrib>Peter Schnider</creatorcontrib><creatorcontrib>Zeiler, Karl</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of the neurological sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lalouschek, Wolfgang</au><au>Aull, Susanne</au><au>Korninger, Lisa</au><au>Mannhalter, Christine</au><au>Pabinger-Fasching, Ingrid</au><au>Schmid, Rainer W</au><au>Peter Schnider</au><au>Zeiler, Karl</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>677C to T mutation in the 5,10-methylenetetrahydrofolate reductase (MTHFR) gene and plasma homocyst(e)ine levels in patients with TIA or minor stroke</atitle><jtitle>Journal of the neurological sciences</jtitle><addtitle>J Neurol Sci</addtitle><date>1998-03-05</date><risdate>1998</risdate><volume>155</volume><issue>2</issue><spage>156</spage><epage>162</epage><pages>156-162</pages><issn>0022-510X</issn><eissn>1878-5883</eissn><coden>JNSCAG</coden><abstract><![CDATA[It was the aim of this study to determine the associations of clinical and laboratory data with plasma homocyst(e)ine levels in patients with transient ischemic attack (TIA) or minor stroke (MS), with special reference to their 677C to T mutation status in the 5,10-methylenetetrahydrofolate reductase (5,10-MTHFR) gene. Seventy-six patients with TIA or MS were investigated at least 3 months after their (last) clinical event. By means of univariate analysis, significant correlations of homocyst(e)ine levels with male gender ( P<0.02), age ( P<0.0005), creatinine levels ( P<0.0002), folate levels (inversely, P<0.05), and alcohol use ( P<0.02) were found, but not with vitamin B 12 levels. Multivariate regression analysis, including age, creatinine levels, and folate levels as independent variables, revealed age ( P<0.01) and creatinine levels ( P<0.02) to be significantly correlated with homocyst(e)ine levels. After adjustment for age, creatinine levels and homocyst(e)ine levels remained significantly correlated to each other ( P<0.005), whereas the relation between folate levels and homocyst(e)ine levels was no longer significant ( P=0.10). Mutation-positive patients exhibited moderately and statistically non-significantly higher homocyst(e)ine levels than mutation-negative patients, particularly those who were homozygous positive. Homocyst(e)ine levels were closely correlated with creatinine levels ( P<0.0002) and with folate levels (inversely, P<0.05), but only in mutation-positive and not in mutation-negative patients. Homozygous positive, heterozygous positive, and mutation-negative patients did not differ with respect to clinical and laboratory data concerning ‘risk factors for stroke’ or co-existing vascular disease. In conclusion, the associations of creatinine levels and, inversely, of folate levels with plasma homocyst(e)ine levels in patients with TIA or MS are dependent on the 5,10-MTHFR mutation status. Significant correlations between these variables were found only in mutation-positive but not in mutation-negative patients.]]></abstract><cop>Shannon</cop><pub>Elsevier B.V</pub><pmid>9562260</pmid><doi>10.1016/S0022-510X(97)00311-0</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0022-510X
ispartof Journal of the neurological sciences, 1998-03, Vol.155 (2), p.156-162
issn 0022-510X
1878-5883
language eng
recordid cdi_proquest_miscellaneous_79813192
source MEDLINE; Elsevier ScienceDirect Journals Complete
subjects 5,10-Methylenetetrahydrofolate Reductase (FADH2)
Adult
Aged
Aged, 80 and over
Analysis of Variance
Biological and medical sciences
Cerebrovascular diseases
Cerebrovascular Disorders - blood
Cerebrovascular Disorders - enzymology
Cerebrovascular Disorders - genetics
Creatinine
Female
Folate
Folic Acid - blood
Genetic disorders
Homocyst(e)ine
Homocysteine - blood
Humans
Ischemic Attack, Transient - blood
Ischemic Attack, Transient - enzymology
Ischemic Attack, Transient - genetics
Male
Medical sciences
Methylenetetrahydrofolate Reductase (NADPH2)
Middle Aged
MTHFR
Mutation - physiology
Neurology
Oxidoreductases - genetics
Risk Factors
Vascular diseases and vascular malformations of the nervous system
Vitamin B 12 - blood
title 677C to T mutation in the 5,10-methylenetetrahydrofolate reductase (MTHFR) gene and plasma homocyst(e)ine levels in patients with TIA or minor stroke
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T13%3A51%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=677C%20to%20T%20mutation%20in%20the%205,10-methylenetetrahydrofolate%20reductase%20(MTHFR)%20gene%20and%20plasma%20homocyst(e)ine%20levels%20in%20patients%20with%20TIA%20or%20minor%20stroke&rft.jtitle=Journal%20of%20the%20neurological%20sciences&rft.au=Lalouschek,%20Wolfgang&rft.date=1998-03-05&rft.volume=155&rft.issue=2&rft.spage=156&rft.epage=162&rft.pages=156-162&rft.issn=0022-510X&rft.eissn=1878-5883&rft.coden=JNSCAG&rft_id=info:doi/10.1016/S0022-510X(97)00311-0&rft_dat=%3Cproquest_cross%3E79813192%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=79813192&rft_id=info:pmid/9562260&rft_els_id=S0022510X97003110&rfr_iscdi=true